The Breast
Volume 19, Issue 3 , Pages 198-201 , June 2010

The rise and fall in menopausal hormone therapy and breast cancer incidence

  • Claudio Pelucchi

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
    • ,
  • Fabio Levi

      Affiliations

    • Unité d’épidémiologie du cancer et Registre vaudois des tumeurs, Institut de medicine sociale et preventive (IUMSP), Centre Hospitalier Universitaire Vaudois et Université de Lausanne, CHUV-Falaises 1, 1011 Lausanne, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 21 3147311; fax: +41 21 3230303.
    • ,
  • Carlo La Vecchia

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
    • Istituto di Statistica Medica e Biometria “G.A. Maccacaro”, Università degli Studi di Milano, Milan, Italy

Received 2 August 2009 ,Revised 27 January 2010 ,Accepted 28 January 2010.

References 

  1. La Vecchia C. Estrogen and combined estrogen–progestogen therapy in the menopause and breast cancer. Breast. 2004;13:515–518
  2. IARC . Combined estrogen–progestogen contraceptives and combined estrogen–progestogen menopausal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Lyon: International Agency for Research on Cancer; 2007;
  3. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1997;350:1047–1059
  4. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  5. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002;360:942–944
  6. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med. 2004;140:184–188
  7. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291:47–53
  8. Glass AG, Lacey JV, Carreon JD, Hoover RN. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99:1152–1161
  9. Kliewer EV, Demers AA, Nugent ZJ. A decline in breast-cancer incidence. N Engl J Med. 2007;357:509–510
  10. Main P, Robinson M. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative. Pharmacoepidemiol Drug Saf. 2008;17:861–868
  11. Parkin DM. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?. Eur J Cancer. 2009;45:1649–1653
  12. Brewster DH, Sharpe KH, Clark DI, Collins J. Declining breast cancer incidence and decreased HRT use. Lancet. 2009;373:459–460
  13. Hemminki E, Kyyronen P, Pukkala E. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995–2005. Maturitas. 2008;61:299–304
  14. Allemand H, Seradour B, Weill A, Ricordeau P. Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer. 2008;95:11–15
  15. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008;107:427–430
  16. Vankrunkelsven P, Kellen E, Lousbergh D, Cloes E, Op de Beeck L, Faes C, et al. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg. Breast Cancer Res Treat. 2009;118:425–432
  17. Soerjomataram I, Coebergh JW, Louwman MW, Visser O, van Leeuwen FE. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?. J Clin Oncol. 2007;25:5038–5039
  18. Morabia A, Costanza MC. Recent reversal of trends in hormone therapy use in a European population. Menopause. 2006;13:111–115
  19. Levi F, Te VC, Randimbison L, Choffat R. Cancer incidence in Vaud, Switzerland (1998–2002). In:  Curado MP,  Edwards B,  Shin HR,  Storm H,  Ferlay J,  Heanue M,  Boyle P editor. Cancer incidence in five continents. IARC Scientific Publications No. 160. vol. IX:Lyon, France: IARC; 2007;
  20. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24:e49–50
  21. Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol. 2007;25:3437–3439
  22. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670–1674
  23. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007;9:R28
  24. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99:1335–1339
  25. Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L. Re: declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008;100:597–598
  26. Signorello LB, Tarone RE. A decline in breast-cancer incidence. N Engl J Med. 2007;357:512–513
  27. Canfell K, Banks E, Moa AM, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust. 2008;188:641–644
  28. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet. 2008;372:608–610
  29. Zahl PH, Maehlen J. A decline in breast-cancer incidence. N Engl J Med. 2007;357:510–511
  30. Suhrke P, Zahl PH, Maehlen J. Declining breast cancer incidence and decreased HRT use. Lancet. 2009;373:460–461
  31. Robbins AS, Clarke CA. Re: declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99:1815
  32. Ringa V, Fournier A. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?]. Rev Epidemiol Sante Publique. 2008;56:297–301
  33. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldman A. Trends in hormone therapy and breast cancer incidence – results from the German Network of Cancer Registries. Pathobiology. 2009;76:90–97
  34. Pollàn M, Pastor-Barriuso A, Ardanaz E, Argüelles M, Martos C, Galcerán J, et al. Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst. 2009;101:1584–1591
  35. Tarone RE. Breast cancer trends among young women in the United States. Epidemiology. 2006;17:588–590
  36. Niclis C, del Pilar Diaz M, La Vecchia C. Breast cancer mortality trends and patterns in Cordoba, Argentina in the period 1986–2006. Eur J Cancer Prev. 2010;19:94–99
  37. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JA, Gass M, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360:573–587
  38. Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control. 2007;18:847–852
  39. Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer. 2003;39:1761–1769
  40. Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer Epidemiol Biomarkers Prev. 2009;18:1763–1769

PII: S0960-9776(10)00038-X

doi: 10.1016/j.breast.2010.01.021

The Breast
Volume 19, Issue 3 , Pages 198-201 , June 2010

Article Tools

* Image Usage & Resolution